LLY - Point Biopharm gains amid regulatory approval potential for increased Eli Lilly bid after SPLASH results
2023-11-15 15:56:02 ET
More on Point Biopharma Global
- POINT Biopharma Global: Why The Market Believes That A Second Bidder May Emerge
- Eli Lilly POINTs Toward Radiopharmaceutical Ambitions
- Eli Lilly extends expiration of tender offer to acquire Point Biopharma
- Point Biopharma quickly gains as big holder comes out against Eli Lilly deal
- Seeking Alpha’s Quant Rating on POINT Biopharma Global
For further details see:
Point Biopharm gains amid regulatory approval, potential for increased Eli Lilly bid after SPLASH results